Looking Into Takeda Pharmaceutical's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Takeda Pharmaceutical's (NYSE:TAK) short percent of float has risen 52.38% since its last report, with 9.93 million shares sold short, which is 0.32% of all regular shares available for trading. It would take traders 5.32 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Takeda Pharmaceutical's peer group average for short interest as a percentage of float is 3.06%, which means the company has less short interest than most of its peers.
October 11, 2023 | 7:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Takeda Pharmaceutical's short interest has increased significantly, indicating a bearish sentiment among investors. However, compared to its peers, the company has less short interest.
The increase in short interest indicates that more investors are betting against Takeda Pharmaceutical, which could put downward pressure on the stock price in the short term. However, the fact that Takeda has less short interest than most of its peers could mitigate this effect to some extent.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100